{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T16:01:21Z","timestamp":1751472081986},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T00:00:00Z","timestamp":1395705600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0092849","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T21:12:55Z","timestamp":1395781975000},"page":"e92849","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Dual Effect of a Polymorphism in the Macrophage Migration Inhibitory Factor Gene Is Associated with New-Onset Graves Disease in a Taiwanese Chinese Population"],"prefix":"10.1371","volume":"9","author":[{"given":"Yu-Huei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Chu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuu-Jen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,3,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1744-313X.2006.00614.x","article-title":"The common -318C\/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves&apos; patients","volume":"33","author":"SZ Han","year":"2006","journal-title":"Int J Immunogenet"},{"key":"ref2","first-page":"2594","article-title":"Clinical practice. Graves&apos; disease","volume":"358","author":"GA Brent","year":"2008","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199311113292007","article-title":"Pathogenesis of Graves&apos; ophthalmopathy","volume":"329","author":"RS Bahn","year":"1993","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1210\/jc.2005-0686","article-title":"A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease","volume":"91","author":"JC Taylor","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Zhao SX, Xue LQ, Liu W, Gu ZH, Pan CM, <etal>et al<\/etal>.. (2013) Robust evidence for five new Graves&apos; disease risk loci from a staged genome-wide association analysis. Hum Mol Genet.","DOI":"10.1093\/hmg\/ddt183"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e57758","DOI":"10.1371\/journal.pone.0057758","article-title":"A refined study of FCRL genes from a genome-wide association study for Graves&apos; disease","volume":"8","author":"SX Zhao","year":"2013","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ng.898","article-title":"A genome-wide association study identifies two new risk loci for Graves&apos; disease","volume":"43","author":"X Chu","year":"2011","journal-title":"Nat Genet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/jhg.2011.99","article-title":"Identification of independent risk loci for Graves&apos; disease within the MHC in the Japanese population","volume":"56","author":"K Nakabayashi","year":"2004","journal-title":"J Hum Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/ejhg.2010.55","article-title":"Follow-up of potential novel Graves&apos; disease susceptibility loci, identified in the UK WTCCC genome-wide nonsynonymous SNP study","volume":"18","author":"PR Newby","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ng.2007.17","article-title":"Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants","volume":"39","author":"PR Burton","year":"2007","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1093\/hmg\/ddp087","article-title":"Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves&apos; disease","volume":"18","author":"OJ Brand","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.153.3731.80","article-title":"Mechanism of a reaction in vitro associated with delayed-type hypersensitivity","volume":"153","author":"BR Bloom","year":"1966","journal-title":"Science"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1084\/jem.179.6.1895","article-title":"The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor","volume":"179","author":"T Calandra","year":"1994","journal-title":"J Exp Med"},{"key":"ref14","first-page":"235","article-title":"Migration inhibitory factor expression in experimentally induced endotoxemia","volume":"150","author":"M Bacher","year":"1997","journal-title":"Am J Pathol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/377068a0","article-title":"MIF as a glucocorticoid-induced modulator of cytokine production","volume":"377","author":"T Calandra","year":"1995","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.4049\/jimmunol.175.9.5611","article-title":"Cutting edge: macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis","volume":"175","author":"ND Powell","year":"2005","journal-title":"J Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.4049\/jimmunol.179.8.5399","article-title":"The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation","volume":"179","author":"T Atsumi","year":"2007","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.30203","article-title":"Macrophage migration inhibitory factor regulates neutrophil chemotactic responses in inflammatory arthritis in mice","volume":"63","author":"LL Santos","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2119\/molmed.2012.00352","article-title":"Macrophage Migration Inhibitory Factor (MIF) and Thyroid Hormone Alterations in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)","volume":"19","author":"M Wendt","year":"2013","journal-title":"Mol Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"8224","DOI":"10.1073\/pnas.1017624108","article-title":"Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity","volume":"108","author":"Y Al-Abed","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.gene.6363867","article-title":"A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis","volume":"3","author":"JA Baugh","year":"2002","journal-title":"Genes Immun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/art.10492","article-title":"Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis","volume":"46","author":"R Donn","year":"2002","journal-title":"Arthritis Rheum"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2008.07.037","article-title":"MIF in autoimmunity and novel therapeutic approaches","volume":"8","author":"S Stosic-Grujicic","year":"2009","journal-title":"Autoimmun Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.gene.6364310","article-title":"Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus","volume":"7","author":"E Sanchez","year":"2006","journal-title":"Genes Immun"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1074\/jbc.275.1.444","article-title":"Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis","volume":"275","author":"S Onodera","year":"2000","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1002\/art.21285","article-title":"Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor","volume":"52","author":"TR Radstake","year":"2005","journal-title":"Arthritis Rheum"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/cc7933","article-title":"Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection","volume":"13","author":"C Ostergaard","year":"2009","journal-title":"Crit Care"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1523-1755.2000.00869.x","article-title":"Expression of macrophage migration inhibitory factor in human glomerulonephritis","volume":"57","author":"HY Lan","year":"2000","journal-title":"Kidney Int"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00467-005-1930-9","article-title":"Association of macrophage migration inhibitory factor -173C allele polymorphism with steroid resistance in children with nephrotic syndrome","volume":"20","author":"A Berdeli","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1046\/j.0022-202x.2001.01366.x","article-title":"High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis","volume":"116","author":"T Shimizu","year":"2001","journal-title":"J Invest Dermatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1167\/iovs.09-4965","article-title":"Association of interleukin-1beta (IL1B) polymorphisms with Graves&apos; ophthalmopathy in Taiwan Chinese patients","volume":"51","author":"YH Liu","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.ophtha.2009.12.037","article-title":"Disease association of the CD103 polymorphisms in Taiwan Chinese Graves&apos; ophthalmopathy patients","volume":"117","author":"YH Liu","year":"2010","journal-title":"Ophthalmology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1423-0127-18-71","article-title":"Association between copy number variation of complement component C4 and Graves&apos; disease","volume":"18","author":"YH Liu","year":"2011","journal-title":"J Biomed Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1423-0127-19-97","article-title":"Association of IL12B polymorphisms with susceptibility to Graves ophthalmopathy in a Taiwan Chinese population","volume":"19","author":"YH Liu","year":"2012","journal-title":"J Biomed Sci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bone.2010.05.009","article-title":"Polymorphisms in the macrophage migration inhibitory factor gene and bone loss in postmenopausal women","volume":"47","author":"M Swanberg","year":"2010","journal-title":"Bone"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cyto.2013.02.024","article-title":"Lack of association between macrophage migration inhibitory factor gene promoter (\u2013173 G\/C) polymorphism and childhood Henoch-Schonlein purpura in Turkish patients","volume":"62","author":"S Nalbantoglu","year":"2013","journal-title":"Cytokine"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/bioinformatics\/btf869","article-title":"Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions","volume":"19","author":"LW Hahn","year":"2003","journal-title":"Bioinformatics"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/gepi.10218","article-title":"Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity","volume":"24","author":"MD Ritchie","year":"2003","journal-title":"Genet Epidemiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/jcem-36-2-358","article-title":"Cell-mediated immunity in Graves&apos; disease and in Hashimoto&apos;s thyroiditis as shown by the demonstration of migration inhibition factor (MIF)","volume":"36","author":"L Lamki","year":"1973","journal-title":"J Clin Endocrinol Metab"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/sj.ejhg.5201485","article-title":"Association of the TSHR gene with Graves&apos; disease: the first disease specific locus","volume":"13","author":"BM Dechairo","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/hmg\/ddr247","article-title":"Association of an SNP with intrathymic transcription of TSHR and Graves&apos; disease: a role for defective thymic tolerance","volume":"20","author":"R Colobran","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0198-8859(97)00024-4","article-title":"Invited anniversary review: HLA associated diseases","volume":"53","author":"E Thorsby","year":"1997","journal-title":"Hum Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.4049\/jimmunol.165.11.6606","article-title":"CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves&apos; disease","volume":"165","author":"T Kouki","year":"2000","journal-title":"J Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/geno.1999.5930","article-title":"Complete sequence determination of the mouse and human CTLA4 gene loci: cross-species DNA sequence similarity beyond exon borders","volume":"60","author":"V Ling","year":"1999","journal-title":"Genomics"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.4049\/jimmunol.0903943","article-title":"Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1","volume":"184","author":"LA Swainson","year":"2010","journal-title":"J Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.4049\/jimmunol.0901982","article-title":"FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling","volume":"183","author":"Y Kochi","year":"2009","journal-title":"J Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0065-2776(08)60598-2","article-title":"Role of macrophage migration inhibitory factor in the regulation of the immune response","volume":"66","author":"CN Metz","year":"1997","journal-title":"Adv Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: a regulator of innate immunity","volume":"3","author":"T Calandra","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1749-6632.2003.tb03220.x","article-title":"Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis","volume":"995","author":"J Nishihira","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S1471-4892(01)00112-6","article-title":"Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery","volume":"1","author":"E Lolis","year":"2001","journal-title":"Curr Opin Pharmacol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B","article-title":"Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids","volume":"42","author":"M Leech","year":"1999","journal-title":"Arthritis Rheum"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/s10165-009-0230-9","article-title":"Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor","volume":"20","author":"LD Kozaci","year":"2010","journal-title":"Mod Rheumatol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00004397-200201000-00014","article-title":"Macrophage migration inhibitory factor in uveitis","volume":"42","author":"S Kotake","year":"2002","journal-title":"Int Ophthalmol Clin"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/0891630310001602984","article-title":"Aberrancies in antigen-presenting cells and T cells in autoimmune thyroid disease. A role in faulty tolerance induction","volume":"36","author":"MO Canning","year":"2003","journal-title":"Autoimmunity"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12026-012-8312-8","article-title":"Delineating the autoimmune mechanisms in Graves&apos; disease","volume":"54","author":"SA Morshed","year":"2012","journal-title":"Immunol Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biomed.2011.10.002","article-title":"Activation of Toll-like receptors induces macrophage migration via the iNOS\/Src\/FAK pathway","volume":"1","author":"MC Maa","year":"2011","journal-title":"BioMedicine"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MOP.0b013e32832cf824","article-title":"Autoimmune thyroid disease: unlocking a complex puzzle","volume":"21","author":"RS Brown","year":"2009","journal-title":"Curr Opin Pediatr"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1517\/14728220903551304","article-title":"Autoimmune diseases: MIF as a therapeutic target","volume":"14","author":"D Greven","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#","article-title":"A novel 5&apos;-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis","volume":"44","author":"RP Donn","year":"2001","journal-title":"Arthritis Rheum"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/art.20178","article-title":"A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis","volume":"50","author":"R Donn","year":"2004","journal-title":"Arthritis Rheum"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1002\/art.30624","article-title":"Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus","volume":"63","author":"A Sreih","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2249.2001.01423.x","article-title":"Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids","volume":"123","author":"L Santos","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1096\/fj.11-195065","article-title":"A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease","volume":"26","author":"P Renner","year":"2012","journal-title":"FASEB J"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1096\/fj.09-129445","article-title":"The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia","volume":"23","author":"S Yende","year":"2009","journal-title":"FASEB J"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0092849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:24:13Z","timestamp":1648686253000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0092849"}},"subtitle":[],"editor":[{"given":"Abhay R.","family":"Satoskar","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,25]]},"references-count":64,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0092849","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,25]]}}}